Very Risky to get caught without your shares at this stage in the game.

I've suspected a couple on this forum of doing that. I believe it is very possible.

can someone break it down for me? the last week, and the next 2-3 months.

what a roller coaster ride this has been. this is great example of "don't invest more than you can afford to lose". although the race is still ongoing, the finish line is unclear to me.

the uptick in volume is the start of major recoil effect. use your patience and reap the reward.

enjoy the weather, drink something cold and try not to over-analyze everyday market action. I am glad to be in so cheaply, I believe that we have a great summer ahead of us. gobble up whatever you can afford.

perspective, aka CATX is "worth" $800 million. we started the race a little late, but we are superior and our "brains" defected that company when it was IsoRay (formerly).
They formed Advanced Medical Isotope, (now) Vivos Inc. It's a marathon folks. get yer popcorn

BDD might expedite IDE review process. Feels like a full 30 day review is highly unlikely.

what's the difference between Trademark and being Registered?

what a great day! IDE submission is still on course. lots of new eyes being captured daily.

the shelf life studies are not a go-no-go criteria. strictly info that enhances IP. I am personally very curious about results if the freeze, thaw, freeze, thaw cycle results.. could be huge advantage if gel can be frozen, long term stored

obviously, if mass amounts can be made and stored, then the end product can be made more affordable, or more profit margin.

there is no further testing on y-90 shelf life. basic isotope theory needed to figure that one out. shelf life experiment on gel alone will help determine the production costs.

hiring a business development manager seems to be a forward looking development.

just the opinion of a dummy

could be that mrs. Bond is still running social media, while new marketing individual focuses on creating more "meat" for the updates. I believe there are multiple people people involved.

reminder, wise man once told me,

"the loudest man in the room, is usually the most ignorant.". ice-scate around on that jewel until the weather warms up

great question

the longer they wait, the better the news will be. trend has been to update quickly upon the close of a quarter. typically 12 days after quarter closes. no news is good news at this stage of the game.

Go daUWgs!

do you have Twitter? I would like to post this summary on there if you don't

choo! choo! all aboard!

obviously you sold and are trying to get back in cheaper. you've lost your credibility, do your own DD pal. we are leaving the station with or without you

sorry pal, but that even though the volume was short lived, it was accumulation and a new floor has been established..

did you know that Dr Krimmins is also on the Board for Exubrion? small world.

I'll see if I can find it and post it, but I think you answered the timeline question yourself already.

I remember reading a response on from Vivos, either on twitter or maybe it was in their update, that the additional nine rabbits would be tested next quarter, and clarified, that "next quarter" was meant as 4th of 2023.

you promise. okay, in 90 days if the price is not less than it is now you can send me the $$$$$ difference. I promise to buy 100,000 at less than . 05 from you.

they are doing a really nice job of dangling the carrot though.

my opinion only, but I think the remaing nine rabbits being tested has more to do with chemistry of gel than the rabbits. testing the freeze/thaw cycle and the effects of radiation on the gel. this will all help determine max shelf life and reduce costs.

Just submit the IDE already, FDA doesn't care about animal data. am I right? SC8?

Just submit the IDE already, FDA doesn't care about animal data. am I right? SC8?

CEO so dumb, collecting data on animals for all these years. waste of time and money. am I right? SC8?

when did we get turd emojis?

rationale, CEO is so stupid, he buys shares on the open market. am I right? SC8? who's with me?

your logic is twisted, in some cases, you have to eat your brussel sprouts before you can have your dessert.

oh wait, that was already tried by the previous "leadership"

your insight is baffling. I guess we could apply for IDE without any background data and use toxic debt to pay for it.

the revenue is a moot point at this juncture in time. knowledge and refinement of product while producing undeniable results is necessary for a small cap that has shallow pockets. "going deep" with a hail mary in the first quarter of the game, as you suggest doing is bad business.

the pet side, Isopet, is the entity keeping us afloat. If you need me to explain how, let me know

Dr. K has indeed conceded that some of the recipe is not protected by patents, but by proprietary trade secrets instead.